Metacon AB gains EU backing for its BIOH2VAP project, marking a strategic milestone in the commercial validation of its hydrogen reforming technology.
Metacon has secured EU project funding for its BIOH2VAP initiative, which focuses on demonstrating hydrogen production from biomethane. This award serves as a critical validation of Metacon's proprietary reforming technology, positioning the company to scale its operations within the European renewable energy market.
The project aims to develop and demonstrate the production of hydrogen using biomethane as a feedstock.
Metacon's fully owned Greek subsidiary, Metacon SA, is the lead entity for the project.
Metacon AB's Greek subsidiary has been awarded EU funding to advance the BIOH2VAP project. The initiative focuses on demonstrating hydrogen production from biomethane, validating the company's proprietary reforming technology in a real-world industrial application.
The project aims to develop and demonstrate the production of hydrogen from biomethane using Metacon's reforming technology.